Stock DBI DEUTSCHE BIOTECH INNOVATIV AG
Add to a list
To use this feature you must be a member
Log inSign up

Financials Deutsche Biotech Innovativ AG Deutsche Boerse AG

Equities

DBI

DE000A0Z25L1

Biotechnology & Medical Research

Market Closed - Deutsche Boerse AG
Other stock markets
 03:13:44 2023-09-26 pm EDT 		5-day change 1st Jan Change
5.05 EUR -.--% Intraday chart for Deutsche Biotech Innovativ AG -.--% -.--%
Jul. 09 Deutsche Biotech Innovativ AG Reports Earnings Results for the Full Year Ended December 31, 2023 CI

Valuation

Fiscal Period: December 2023
Capitalization 1 8.526
Enterprise Value (EV) 1 8.509
P/E ratio -
Yield -
Capitalization / Revenue -
EV / Revenue -
EV / EBITDA -125 x
EV / FCF -8.88 x
FCF Yield -11.3%
Price to Book -
Nbr of stocks (in thousands) 947
Reference price 2 9.000
Announcement Date 7/9/24
1EUR in Million2EUR
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales 1 0.1204 - - - - -
EBITDA 1 -0.1611 -0.0887 -0.371 -0.1985 -0.008406 -0.0683
EBIT 1 -0.1641 -0.0894 -0.373 -0.2015 -0.1104 -0.0703
Operating Margin -136.33% - - - - -
Earnings before Tax (EBT) 1 -0.1654 -0.4045 -0.385 -0.2233 -0.2364 -1.092
Net income 1 -0.1654 -0.4045 -0.385 -0.2233 -0.2364 -1.092
Net margin -137.39% - - - - -
EPS 2 -0.1746 -0.4270 - -0.2357 -0.2496 -
Free Cash Flow 1 -0.0745 0.1056 0.5091 0.1667 -0.4146 -0.9586
FCF margin -61.9% - - - - -
FCF Conversion (EBITDA) - - - - - -
FCF Conversion (Net income) - - - - - -
Dividend per Share - - - - - -
Announcement Date 6/28/19 8/13/20 6/5/23 6/5/23 6/5/23 7/9/24
1EUR in Million2EUR
Estimates

Balance Sheet Analysis

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt 1 - - - - - -
Net Cash position 1 0.14 0.11 0.03 0.02 0.01 0.02
Leverage (Debt/EBITDA) - - - - - -
Free Cash Flow 1 -0.07 0.11 0.51 0.17 -0.41 -0.96
ROE (net income / shareholders' equity) -8.21% -23.4% -28.9% -21.7% -29.6% -320%
ROA (Net income/ Total Assets) -4.67% -2.69% -11% -5.54% -3.12% -2.34%
Assets 1 3.538 15.01 3.497 4.032 7.574 46.74
Book Value Per Share 2 2.040 1.610 - 0.9700 0.7200 -
Cash Flow per Share 2 0.1500 0.1200 - 0.0200 0.0100 -
Capex 1 0 - 0.01 - - 0.97
Capex / Sales 1.66% - - - - -
Announcement Date 6/28/19 8/13/20 6/5/23 6/5/23 6/5/23 7/9/24
1EUR in Million2EUR
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Other Biotechnology & Medical Research

1st Jan change Capi.
MODERNA, INC. Stock Moderna, Inc.
+22.10% 46.55B
LONZA GROUP AG Stock Lonza Group AG
+46.45% 41.84B
IQVIA HOLDINGS INC. Stock Iqvia Holdings Inc.
-3.12% 40.84B
ALNYLAM PHARMACEUTICALS, INC. Stock Alnylam Pharmaceuticals, Inc.
+36.10% 32.95B
CELLTRION, INC. Stock Celltrion, Inc.
-6.30% 28.27B
ICON PUBLIC LIMITED COMPANY Stock ICON Public Limited Company
+18.71% 27.78B
UNITED THERAPEUTICS CORPORATION Stock United Therapeutics Corporation
+46.15% 14.26B
MEDPACE HOLDINGS, INC. Stock Medpace Holdings, Inc.
+44.52% 13.69B
BIO-TECHNE CORPORATION Stock Bio-Techne Corporation
+0.19% 12.18B
Other Biotechnology & Medical Research
  1. Stock Market
  2. Equities
  3. DBI Stock
  4. DBI Stock
  5. Financials Deutsche Biotech Innovativ AG